Actively Recruiting
Comparing Topical Nadifloxacin Plus Tretinoin Cream to Clindamycin Plus Tretinoin Cream for Treatment of Mild-to-Moderate Acne Vulgaris
Led by Nishtar Medical University · Updated on 2026-11-04
158
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This trial compares two topical combination treatments for adults aged 18 to 40 with mild-to-moderate acne vulgaris. The study evaluates the effectiveness of 1% nadifloxacin plus 0.025% tretinoin cream against 1% clindamycin plus 0.025% tretinoin cream. The goal is to see which treatment better reduces inflammatory acne lesions after 12 weeks, with focus on newly diagnosed patients without certain other medical conditions. Participants are randomly assigned to apply either nadifloxacin with tretinoin or clindamycin with tretinoin once daily at bedtime to the entire affected facial area after washing and drying the skin. They also use a non-comedogenic moisturizer and sunscreen and avoid other acne treatments. Treatment lasts 12 weeks, with follow-up visits at 4, 8, and 12 weeks to check medication use and side effects. Before treatment and after 12 weeks, a dermatologist unaware of the assigned treatment counts inflammatory, non-inflammatory, and total acne lesions and grades severity using a standardized acne grading system. Side effects like redness, dryness, and itching are monitored at each visit. The main outcome is the reduction in inflammatory lesions at 12 weeks, with secondary measures including overall lesion reduction and acne severity changes.
CONDITIONS
Brief Title
Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne
Research Team
M
Muhammad T Suleman, MBBS
R
Raheel T Associate Professor, FCPS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here